
Marcus Schindler
February 20
Dr Marcus Schindler is the Chief Scientific Officer (CSO) of Novo Nordisk, a leading global healthcare company and Europe’s most valuable company, recently gaining significant public attention for its innovative treatments in weight management, obesity care, and diabetes. With extensive experience in pharmaceutical research and development, Dr Schindler plays a pivotal role in driving scientific innovation at Novo Nordisk, helping to develop groundbreaking therapies that improve the lives of patients worldwide.